{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T19:22:00Z","timestamp":1793906520703,"version":"4.8.0"},"reference-count":58,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.autrev.2022.103135","type":"journal-article","created":{"date-parts":[[2022,6,9]],"date-time":"2022-06-09T17:12:06Z","timestamp":1654794726000},"page":"103135","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":58,"title":["Autoimmune polyendocrine syndrome type 1: Clinical manifestations, pathogenetic features, and management approach"],"prefix":"10.1016","volume":"21","author":[{"given":"Geir","family":"Bj\u00f8rklund","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maksim","family":"Pivin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tony","family":"Hangan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oksana","family":"Yurkovskaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lyudmila","family":"Pivina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2022.103135_bb0005","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s13023-021-02170-z","article-title":"Molecular and clinical characterization of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy syndrome (APECED) in Iranian non-Jewish patients: report of two novel AIRE gene pathogenic variants","volume":"17","author":"Setoodeh","year":"2022","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.autrev.2022.103135_bb0010","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1590\/S0004-27302012000100009","article-title":"Autoimmune polyendocrine syndrome type 1: case report and review of literature","volume":"56","author":"Weiler","year":"2012","journal-title":"Arq Bras Endocrinol Metabol"},{"key":"10.1016\/j.autrev.2022.103135_bb0015","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.1210\/jc.2005-2611","article-title":"Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy","volume":"91","author":"Perheentupa","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.autrev.2022.103135_bb0020","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1056\/NEJM199006283222601","article-title":"Clinical variation of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) in a series of 68 patients","volume":"322","author":"Ahonen","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2022.103135_bb0025","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.autrev.2017.11.012","article-title":"The immunobiology and clinical features of type 1 autoimmune polyglandular syndrome (APS-1)","volume":"17","author":"Guo","year":"2018","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2022.103135_bb0030","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1086\/302765","article-title":"Mutations in the AIRE gene: efects on subcellular location and transac- tivation function of the autoimmune polyendocrinopathy-candidiasis\u2013 ectodermal dystrophy protein","volume":"66","author":"Bj\u00f6rses","year":"2000","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.autrev.2022.103135_bb0035","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1136\/jmg.29.11.824","article-title":"Polyglandular autoimmune syndrome type I among Iranian Jews","volume":"29","author":"Zlotogora","year":"1992","journal-title":"J Med Genet"},{"key":"10.1016\/j.autrev.2022.103135_bb0040","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/ng1297-393","article-title":"Positional cloning of the APECED gene","volume":"17","author":"Nagamine","year":"1997","journal-title":"Nat Genet"},{"key":"10.1016\/j.autrev.2022.103135_bb0045","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1007\/s004390050846","article-title":"A common mutation in Sardinian autoimmune polyendocrinopathy-candidia- sis-ectodermal dystrophy patients","volume":"103","author":"Rosatelli","year":"1998","journal-title":"Hum Genet"},{"key":"10.1016\/j.autrev.2022.103135_bb0050","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.berh.2016.04.003","article-title":"Primary Sj\u00f6gren\u2019s syndrome","volume":"30","author":"Rischmueller","year":"2016","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.1016\/j.autrev.2022.103135_bb0055","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.lpm.2012.10.005","article-title":"Polyglandular autoimmune syndrome type I","volume":"41","author":"Proust-Lemoine","year":"2012","journal-title":"La Presse Medicale"},{"key":"10.1016\/j.autrev.2022.103135_bb0060","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1210\/jcem.83.4.4682","article-title":"Clinical review 93: autoimmune polyglandular syndrome type 1","volume":"83","author":"Betterle","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.autrev.2022.103135_bb0065","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1210\/jc.2006-1873","article-title":"Autoimmune polyendocrine syndrome type 1 in Norway: phenotypic variation, autoantibodies, and novel mutations in the autoimmune regulator gene","volume":"92","author":"Wolff","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.autrev.2022.103135_bb0070","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1515\/JPEM.2006.19.11.1343","article-title":"Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) in the Irish population","volume":"19","author":"Dominguez","year":"2006","journal-title":"J Pediatr Endocrinol Metab"},{"key":"10.1016\/j.autrev.2022.103135_bb0075","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1007\/s40618-021-01585-6","article-title":"Autoimmune polyendocrine syndrome type 1: an Italian survey on 158 patients","volume":"44","author":"Garelli","year":"2021","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.autrev.2022.103135_bb0080","first-page":"19","article-title":"Polyendocrinopathies auto-immunes de type 1: caract\u00e9ristiques cliniques et \u00e9volutives sur la base d\u2019une enqu\u00eate interr\u00e9gionale et nationale [Autoimmune polyendocrine syndrome type 1: clinical features and course in France]","volume":"197","author":"Wemeau","year":"2013","journal-title":"Bull Acad Natl Med"},{"key":"10.1016\/j.autrev.2022.103135_bb0085","doi-asserted-by":"crossref","first-page":"98","DOI":"10.3389\/fimmu.2018.00098","article-title":"Twenty years of AIRE","volume":"9","author":"Perniola","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2022.103135_bb0090","doi-asserted-by":"crossref","first-page":"248","DOI":"10.6065\/apem.2019.24.4.248","article-title":"A novel compound heterozygous mutation of the AIRE gene in a patient with autoimmune polyendocrine syndrome type 1","volume":"24","author":"Suh","year":"2019","journal-title":"Ann Pediatr Endocrinol Metab"},{"key":"10.1016\/j.autrev.2022.103135_bb0095","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/j.1399-0004.1985.tb02037.x","article-title":"Autoimmune polyendocrinopathy \u2014 candidosis \u2014 ectodermal dystrophy (apeced): autosomal recessive inheritance","volume":"27","author":"Ahonen","year":"2008","journal-title":"Clin Genet"},{"key":"10.1016\/j.autrev.2022.103135_bb0100","first-page":"95","article-title":"Autoimmune polyendocrinopathy \u2014 candidosis \u2014ectodermal dystrophy (apeced) \u2014 a diagnostic and therapeutic challenge","volume":"7","author":"J\u00e4\u00e4skel\u00e4inen","year":"2009","journal-title":"Pediatr Endocrinol Rev"},{"key":"10.1016\/j.autrev.2022.103135_bb0105","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1056\/NEJMra1713301","article-title":"Autoimmune polyendocrine syndromes","volume":"378","author":"Husebye","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2022.103135_bb0110","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1159\/000313585","article-title":"Autoimmune polyglandular syndrome type 1 in Russian patients: clinical variants and autoimmune regulator mutations","volume":"73","author":"Orlova","year":"2010","journal-title":"Horm Res Paediatr"},{"key":"10.1016\/j.autrev.2022.103135_bb0115","first-page":"86","article-title":"APECED: a paradigm of complex interactions between genetic background and susceptibility factors","volume":"4","author":"De Martino","year":"2007","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2022.103135_bb0120","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1086\/302145","article-title":"Common and recurrent 13-bp deletion in the autoimmune regulator gene in British kindreds with autoimmune polyendocrinopathy type 1","volume":"63","author":"Pearce","year":"1998","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.autrev.2022.103135_bb0125","doi-asserted-by":"crossref","first-page":"154","DOI":"10.3928\/0090-4481-19800401-07","article-title":"Autoimmune polyglandular syndromes","volume":"9","author":"Neufeld","year":"1980","journal-title":"Pediatr Ann"},{"key":"10.1016\/j.autrev.2022.103135_bb0130","series-title":"Symposium on autoimmune aspects of endocrine disorders","first-page":"357","article-title":"Polyglandular autoimmune diseases","author":"Neufeld","year":"1980"},{"key":"10.1016\/j.autrev.2022.103135_bb0135","doi-asserted-by":"crossref","first-page":"5502","DOI":"10.3390\/ijms22115502","article-title":"Multiplex autoantibody detection in patients with autoimmune Polyglandular syndromes","volume":"22","author":"Savvateeva","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.autrev.2022.103135_bb0140","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1126\/science.1075958","article-title":"Projection of an immunological self-shadow within the thymus by the AIRE protein","volume":"298","author":"Anderson","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.autrev.2022.103135_bb0145","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0030289","article-title":"Anti-interferon autoantibodies in autoimmune polyendocrinopathy syndrome type 1","volume":"3","author":"Meager","year":"2006","journal-title":"PLoS Med"},{"key":"10.1016\/j.autrev.2022.103135_bb0150","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.0105-2896.2004.00204.x","article-title":"Interferons, interferon-like cytokines, and their receptors","volume":"202","author":"Pestka","year":"2004","journal-title":"Immunol Rev"},{"key":"10.1016\/j.autrev.2022.103135_bb0155","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/ni0103-8","article-title":"Novel interferons","volume":"4","author":"Vilcek","year":"2003","journal-title":"Nat Immunol"},{"key":"10.1016\/j.autrev.2022.103135_bb0160","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.1182\/blood-2008-03-144634","article-title":"Interferon autoantibodies associated with AIRE deficiency decrease the expression of ifnstimulated genes","volume":"112","author":"Kisand","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2022.103135_bb0165","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.clim.2014.04.013","article-title":"A novel cell-based assay for measuring neutralizing autoantibodies against type i interferons in patients with autoimmune polyendocrine syndrome type 1","volume":"153","author":"Breivik","year":"2014","journal-title":"Clin Immunol"},{"key":"10.1016\/j.autrev.2022.103135_bb0170","doi-asserted-by":"crossref","first-page":"544","DOI":"10.3389\/fimmu.2018.00544","article-title":"Neutralizing anti-cytokine autoantibodies against interferon-\u03b1 in Immunodysregulation polyendocrinopathy enteropathy X-linked","volume":"29","author":"Rosenberg","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2022.103135_bb0175","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1210\/jc.2003-030279","article-title":"Prevalence and clinical associations of ten defined autoantibodies in autoimmune polyendocrine syndrome type I","volume":"89","author":"S\u00f6derbergh","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.autrev.2022.103135_bb0180","first-page":"1871","article-title":"Autoantibodies to steroidogenic enzymes in autoimmune polyglandular syndrome, Addison\u2019s disease, and premature ovarian failure","volume":"81","author":"Chen","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.autrev.2022.103135_bb0185","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1093\/intimm\/dxm118","article-title":"Testis-expressed protein TSGA10 an auto-antigen in autoimmune polyendocrine syndrome type I","volume":"20","author":"Reimand","year":"2008","journal-title":"Int Immunol"},{"key":"10.1016\/j.autrev.2022.103135_bb0190","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1056\/NEJMoa0706487","article-title":"Autoimmune polyendocrine syndrome type 1 and NALP5, a parathyroid autoantigen","volume":"358","author":"Alimohammadi","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2022.103135_bb0195","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1172\/JCI116843","article-title":"Two different cytochrome P450 enzymes are the adrenal antigens in autoimmune polyendocrine syndrome type I and Addison\u2019s disease","volume":"92","author":"Winqvist","year":"1993","journal-title":"J Clin Invest"},{"key":"10.1016\/j.autrev.2022.103135_bb0200","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1530\/EC-20-0328","article-title":"Familial associations for Addison\u2019s disease and between Addison\u2019s disease and other autoimmune diseases","volume":"9","author":"Thomsen","year":"2020","journal-title":"Endocr Connect"},{"key":"10.1016\/j.autrev.2022.103135_bb0205","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1006\/bbrc.1999.1945","article-title":"Identification of tyrosine hydroxylase as an autoantigen in autoimmune polyendocrine syndrome type I","volume":"267","author":"Hedstrand","year":"2000","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.autrev.2022.103135_bb0210","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.ebiom.2019.08.036","article-title":"High-throughput multiplexed autoantibody detection to screen type 1 diabetes and multiple autoimmune diseases simultaneously","volume":"47","author":"Gu","year":"2019","journal-title":"EBioMedicine."},{"key":"10.1016\/j.autrev.2022.103135_bb0215","doi-asserted-by":"crossref","first-page":"161","DOI":"10.2337\/diab.43.1.161","article-title":"GAD autoantibodies in IDDM, stiffman syndrome, and autoimmune polyendocrine syndrome type I recognize different epitopes","volume":"43","author":"Bj\u00f6rk","year":"1994","journal-title":"Diabetes"},{"key":"10.1016\/j.autrev.2022.103135_bb0220","series-title":"Integrated endocrinology","author":"Laycock","year":"2013"},{"key":"10.1016\/j.autrev.2022.103135_bb0225","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.bone.2018.09.018","article-title":"Advances in the treatment of hypoparathyroidism with PTH 1-34","volume":"120","author":"Winer","year":"2019","journal-title":"Bone"},{"key":"10.1016\/j.autrev.2022.103135_bb0230","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1210\/jc.2015-1710","article-title":"Diagnosis and treatment of primary adrenal insufficiency: an endocrine society clinical practice guideline","volume":"101","author":"Bornstein","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.autrev.2022.103135_bb0235","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1111\/j.1365-2796.2009.02090.x","article-title":"Clinical manifestations and management of patients with autoimmune polyendocrine syndrome type I","volume":"265","author":"Husebye","year":"2009","journal-title":"J Intern Med"},{"key":"10.1016\/j.autrev.2022.103135_bb0240","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1684\/ejd.2020.3811","article-title":"Alopecia areata with autoimmune polyglandular syndrome type 3 showing type 1\/Tc1 immunological inflammation","volume":"30","author":"Hanai","year":"2020","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.autrev.2022.103135_bb0245","doi-asserted-by":"crossref","DOI":"10.1186\/s13052-021-01075-8","article-title":"Report of two siblings with APECED in Serbia: is there a founder effect of c.769C>T AIRE genotype?","volume":"47","author":"Fierabracci","year":"2021","journal-title":"Ital J Pediatr"},{"key":"10.1016\/j.autrev.2022.103135_bb0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.clindermatol.2022.02.009","article-title":"The genetics of pediatric cutaneous autoimmunity: the sister diseases vitiligo and alopecia areata","author":"Silverberg","year":"2022","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.autrev.2022.103135_bb0255","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1080\/1744666X.2021.1925543","article-title":"Clinical, immunological, and genetic features in 938 patients with autoimmune polyendocrinopathy candidiasis ectodermal dystrophy (APECED): a systematic review","volume":"17","author":"Sharifinejad","year":"2021","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.autrev.2022.103135_bb0260","doi-asserted-by":"crossref","first-page":"558","DOI":"10.3390\/genes13040558","article-title":"Clinical characteristics in the longitudinal follow-up of APECED syndrome in southern Croatia-case series","volume":"13","author":"Skrabic","year":"2022","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.autrev.2022.103135_bb0265","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1186\/s13023-021-01933-y","article-title":"Characterization of the clinical and genetic spectrum of autoimmune polyendocrine syndrome type 1 in Chinese case series","volume":"16","author":"Wang","year":"2021","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.autrev.2022.103135_bb0270","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1093\/jac\/dkq354","article-title":"Persistent Candida albicans colonization and molecular mechanisms of azole resistance in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) patients","volume":"65","author":"Siikala","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.autrev.2022.103135_bb0275","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.oraloncology.2006.07.005","article-title":"Oral and oesophageal squamous cell carcinoma \u2013 a complication or component of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED, APS-I)","volume":"43","author":"Rautemaa","year":"2007","journal-title":"Oral Oncol"},{"key":"10.1016\/j.autrev.2022.103135_bb0280","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0889-8529(01)00013-5","article-title":"APS-I\/APECED: the clinical disease and therapy","volume":"31","author":"Perheentupa","year":"2002","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1016\/j.autrev.2022.103135_bb0285","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1002\/ppul.21520","article-title":"Autoimmune polyendocrine syndrome type 1: utility of KCNRG autoantibodies as a marker of active pulmonary disease and successful treatment with rituximab","volume":"47","author":"Popler","year":"2012","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.autrev.2022.103135_bb0290","first-page":"43","article-title":"Sindrome poliendocrina autoimmune. Trattamento con immunoglobuline endovena [autoimmune polyendocrine syndrome. Treatment with intravenous immunoglobulins]","volume":"141","author":"Antonelli","year":"1992","journal-title":"Clin Ter"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997222001057?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997222001057?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T21:26:36Z","timestamp":1761600396000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997222001057"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":58,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["S1568997222001057"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2022.103135","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Autoimmune polyendocrine syndrome type 1: Clinical manifestations, pathogenetic features, and management approach","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2022.103135","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"103135"}}